Abstract
Prostaglandin E1 (PGE1) administration for palliation of cyanotic congenital heart disease in neonates has been associated with radiographically visible necrosis of brown fat about the neck and shoulder girdles. However, the natural history of this process has not been described. We present two patients with cyanotic congenital heart disease, treated preoperatively with prostaglandin E2 (PGE2), both of whom developed dramatic calcific brown fat necrosis. This process slowly resolved over time in both patients.
Similar content being viewed by others
References
Aherne W, Hull D (1966) Brown adipose tissue and heat production in the newborn infant. J Pathol Bacteriol 91:223–234
Stephenson TJ, Variend S (1987) Visceral brown fat necrosis in postperinatal mortality. J Clin Pathol 40:896–900
Raboi CA, Smith W (1999) Brown fat necrosis in the setting of congenital heart disease and prostaglandin E1 use: a case report. Pediatr Radiol 29:61–63
Cohade C, Osman M, Pannu HK, et al (2003) Uptake in supraclavicular area fat (“USA-fat”): description on 18F-FDG PET/CT. J Nucl Med 44:170–176
Okuyama C, Ushijima Y, Kubota T, et al (2003) 123-I-metaiodobenzylguanidine uptake in the nape of the neck of children: likely visualization of brown adipose tissue. J Nucl Med 44:1421–1425
Yeung HWD, Grewal RK, Gonen M, et al (2003) Patterns of 18F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med 44:1789–1796
Fukuchi K, Ono Y, Nakahata Y, et al (2003) Visualization of interscapular brown adipose tissue using 99mTc-Tetrofosmin in pediatric patients. J Nucl Med 44:1582–1585
Arch JRS, Ainsworth AT, Cawthorne MA, et al (1984) Atypical B-adrenoreceptor on brown adipocytes as target for anti-obesity drugs. Nature 309:163–164
Heaton JM (1972) The distribution of brown adipose tissue in the human. J Anat 112: 35–39
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miller, S.F. Resolution of calcific brown fat necrosis associated with prostaglandin therapy for cyanotic congenital heart disease in neonates: report of two cases. Pediatr Radiol 34, 919–923 (2004). https://doi.org/10.1007/s00247-004-1231-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-004-1231-7